| Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma (NCT03229278) | Rutgers, The State University of New Jersey | 2017-10-03 |
| Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer (NCT03092856) | University of Southern California | 2017-07-19 |
| Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer (NCT02899078) | University of California, Davis | 2016-11-15 |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer (NCT02843607) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer (NCT02626130) | M.D. Anderson Cancer Center | 2016-03-30 |
| Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer (NCT02579811) | Case Comprehensive Cancer Center | 2015-12-30 |
| Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma (NCT02555748) | Institut Claudius Regaud | 2015-11-17 |
| Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer (NCT02664883) | University of Southern California | 2015-09-08 |
| 18F-FSPG PET/CT for Cancer Patients on Therapy (NCT02599194) | Andrei Iagaru | 2015-07-01 |
| Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer (NCT02542202) | University of Chicago | 2015-05-01 |
| Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer (NCT02318771) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-02-05 |
| Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma (NCT01926990) | Stanford University | 2014-08-01 |
| Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer (NCT02089334) | Rexahn Pharmaceuticals, Inc. | 2014-08-01 |
| Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer (NCT01767636) | Mayo Clinic | 2013-05-16 |
| A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers (NCT01743469) | Ipsen | 2012-12-01 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer (NCT01462214) | Hans J. van der Vliet, MD, PhD | 2011-10-01 |
| A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer (NCT01829841) | Jiangsu HengRui Medicine Co., Ltd. | 2011-05-01 |
| Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib (NCT01246843) | Radboud University Medical Center | 2009-07-01 |
| A Phase 1b Trial in Patients With Renal Cell Cancer (NCT01258348) | Eli Lilly and Company | 2008-07-01 |
| Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer (NCT00670748) | National Cancer Institute (NCI) | 2008-05-29 |
| A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. (NCT00428220) | Pfizer | 2007-07-01 |
| Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer (NCT00027820) | Fred Hutchinson Cancer Center | 2001-08-01 |